Summary
CVS Health Corporation reported strong top-line growth in the third quarter of 2016, with net revenues increasing by 15.5% year-over-year, driven by acquisitions and organic growth in its Pharmacy Services and Retail/LTC segments. The company demonstrated robust operating profit growth, up 20.8% year-over-year, reflecting effective expense management and synergies from recent acquisitions. While revenue and profit figures are positive, investors should note a slight decrease in gross profit margin, attributed to a changing business mix and ongoing price compression in the Pharmacy Services segment. The company also incurred significant expenses related to the early extinguishment of debt, impacting net income. Despite these factors, CVS Health continues to execute its strategy, evidenced by substantial share repurchases and a new $15 billion repurchase program authorization, signaling confidence in future performance and commitment to shareholder returns.
Financial Highlights
56 data points| Revenue | $44.62B |
| Cost of Revenue | $37.12B |
| Gross Profit | $7.49B |
| Operating Expenses | $4.67B |
| Operating Income | $2.82B |
| Interest Expense | $258.00M |
| Net Income | $1.54B |
| EPS (Basic) | $1.44 |
| EPS (Diluted) | $1.43 |
| Shares Outstanding (Basic) | 1.07B |
| Shares Outstanding (Diluted) | 1.07B |
Key Highlights
- 1Net revenues increased by 15.5% to $44.6 billion for the third quarter of 2016 compared to the prior year, driven by acquisitions (Omnicare, Target pharmacies) and growth in Pharmacy Services and Retail/LTC segments.
- 2Operating profit saw a significant increase of 20.8% to $2.8 billion for the quarter, indicating effective cost management and integration of acquisitions.
- 3Gross profit dollars grew by 12.5% to $7.5 billion, though the gross profit margin slightly compressed by 45 basis points to 16.8% due to business mix changes and price pressures.
- 4The company repurchased approximately $4.0 billion of its common stock during the first nine months of 2016 and announced a new $15 billion share repurchase program.
- 5A substantial loss on early extinguishment of debt of $101 million was recorded in the third quarter, and $643 million year-to-date, related to debt refinancing activities.
- 6Diluted earnings per share from continuing operations increased to $1.43, up from $1.10 in the prior year's quarter.
- 7Integration costs related to the Omnicare and Target acquisitions were noted across segments, with Retail/LTC segment seeing significant integration costs impacting operating profit.